Home | Site Map | Help
Welcome

ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders.

Learn more

 Programs

We are developing a portfolio of clinical-stage drug candidates aimed at large market opportunities in schizophrenia, Parkinson's disease psychosis, sleep maintenance insomnia, neuropathic pain and other central nervous system disorders. We currently have five programs in clinical development.

Learn more

 Technology

Our proprietary drug discovery platform combines target-based and chemistry-based technologies to enable efficient discovery of new compounds that may serve as potential treatments for significant unmet medical needs.

Learn more